CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

Transition of Macrophages to Fibroblast-Like Cells in Healing Myocardial Infarction Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct Administration The Prognostic Significance of Periprocedural Infarction in the Era of Potent Antithrombotic Therapy: The PRAGUE-18 Substudy Acute Myocardial Injury in Patients Hospitalized With COVID-19 Infection: A Review Long-term outcomes after myocardial infarction in middle-aged and older patients with congenital heart disease-a nationwide study Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry

Original Research2019 Jul;12(7):e005103.

JOURNAL:Circ Cardiovasc Qual Outcomes. Article Link

Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients

Shavadia JS, Holmes DN, Thomas L et al. Keywords: 3-year post-MI survivors; β-blocker; elderly; observational study; long-term cardiovascular outcomes

FULL TEXT PDF